December 9, 2011
Osaka Prefecture announced on December 7 that Osaka Bio Fund, established in March last year together with local pharmaceutical companies and other organizations in Osaka, has chosen ImmunoFrontier, Inc., a drug discovery venture company based in Tokyo as its No.3...read more